Obesity and cancer

Affiliations

¹ Division of Endocrinology, Diabetes and Bone Disease, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Emily.Gallagher@mssm.edu.
² Division of Endocrinology, Diabetes and Bone Disease, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Editorial

Emily J Gallagher et al. Cancer Metastasis Rev. 2022 Sep.

. 2022 Sep;41(3):463-464.

doi: 10.1007/s10555-022-10049-z.

¹ Division of Endocrinology, Diabetes and Bone Disease, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Emily.Gallagher@mssm.edu.
² Division of Endocrinology, Diabetes and Bone Disease, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

No abstract available

References

1. Bluher M Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288–298. - PubMed
1. Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med. 2016;375(8):794–798. - PMC - PubMed
1. Pearson-Stuttard J, Zhou B, Kontis V, Bentham J, Gunter MJ, Ezzati M. Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment. Lancet Diabetes Endocrinol. 2018;6(6):e6–e15. - PMC - PubMed
1. Larsson SC, Burgess S. Causal role of high body mass index in multiple chronic diseases: a systematic review and meta-analysis of Mendelian randomization studies. BMC Med. 2021;19(1):320. - PMC - PubMed
1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. - PubMed